MAXHEALTH — Max Healthcare Institute Income Statement
0.000.00%
- IN₹995.87bn
- IN₹1.02tn
- IN₹83.73bn
Annual income statement for Max Healthcare Institute, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 39,315 | 45,626 | 54,060 | 70,285 | 83,735 |
| Cost of Revenue | |||||
| Gross Profit | 29,459 | 35,717 | 42,100 | 54,364 | 65,834 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 32,007 | 35,511 | 41,469 | 55,858 | 66,254 |
| Operating Profit | 7,308 | 10,116 | 12,592 | 14,427 | 17,481 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 7,389 | 10,637 | 13,653 | 14,064 | 16,756 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6,051 | 11,035 | 10,576 | 10,759 | 14,424 |
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 6,051 | 11,035 | 10,576 | 10,759 | 14,424 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 6,051 | 11,035 | 10,576 | 10,759 | 14,424 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 6.34 | 11.3 | 10.8 | 11.6 | 15.2 |
| Dividends per Share |